Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.7859 USD | +6.20% | +4.02% | -73.18% |
14.03. | Top Absteiger am Mittag | MT |
14.03. | Sektor-Update: Aktien des Gesundheitswesens am Donnerstagnachmittag niedriger | MT |
Kurzporträt
Mitarbeiterzahl: 29
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 54 | 03.01.22 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 01.05.20 |
Michael Grey
CHM | Chairman | 71 | 01.04.17 |
P. J. Ramtin
COO | Chief Operating Officer | - | 10.08.22 |
Ralph Charlton
CTO | Chief Tech/Sci/R&D Officer | 54 | 14.03.22 |
Libbie Mansell
LAW | General Counsel | - | 11.04.22 |
SAba Sile
PRN | Corporate Officer/Principal | - | 10.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 09.09.20 |
Michael Grey
CHM | Chairman | 71 | 01.04.17 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 01.05.16 |
Kirk Ways
BRD | Director/Board Member | 72 | 23.06.21 |
Niall O'Donnell
BRD | Director/Board Member | 51 | 01.05.16 |
Director/Board Member | - | 25.05.23 | |
Bali Muralidhar
BRD | Director/Board Member | 44 | 01.02.20 |
Camilla Simpson
BRD | Director/Board Member | 52 | 13.11.17 |
Chief Executive Officer | 54 | 03.01.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 41 149 160 | 39 186 760 ( 95,23 %) | 0 | 95,23 % |
Unternehmenskontakt
Spruce Biosciences, Inc.
611 Gateway Boulevard Suite 740
94080, South San Francisco
+
http://www.sprucebio.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-73.18% | 32.34 Mio. | |
+9.30% | 46.03 Mrd. | |
+52.73% | 44.55 Mrd. | |
+7.15% | 40.8 Mrd. | |
-8.78% | 28.25 Mrd. | |
+18.68% | 27.71 Mrd. | |
-21.92% | 18.82 Mrd. | |
+14.62% | 13.91 Mrd. | |
+31.85% | 12.43 Mrd. | |
+4.47% | 10.81 Mrd. |
- Börse
- Aktien
- Aktie Spruce Biosciences, Inc. - Nasdaq
- Unternehmen Spruce Biosciences, Inc.